Skip to main content
Erschienen in: Inflammation 2/2016

05.02.2016 | ORIGINAL ARTICLE

Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway

verfasst von: Weifeng Li, Xiumei Wang, Xiaofeng Niu, Hailin Zhang, Zehong He, Yu Wang, Wenbing Zhi, Fang Liu

Erschienen in: Inflammation | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Nobiletin (NOB), the major bioactive component of polymethoxyflavones in citrus fruits, has been reported possessing significant biological properties. The purpose of the present study was to investigate the protective role of NOB on lipopolysaccharide (LPS)-induced endotoxic shock in mice. We found pretreatment with NOB increases the survival rate of mice after endotoxin injection. The present study clearly demonstrates that pretreatment with NOB decreases the production of early pro-inflammatory cytokines TNF-α, IL-6, and late-phase mediator HMGB1 in serum and tissues of kidney, lung, and liver. The histopathological study indicates that NOB administration significantly attenuate tissues injury induced by LPS. Moreover, NOB suppresses the activity of nuclear factor-kappa B (NF-κB). These results suggest that NOB protects mice against LPS-induced endotoxic shock through inhibiting the production of TNF-α, IL-6, and HMGB1 and the activation of NF-κB, which elucidate that NOB may be a promising drug candidate for the treatment of septic shock.
Literatur
1.
Zurück zum Zitat Karima, R., S. Matsumoto, H. Higashi, and K. Matsushima. 1999. The molecular pathogenesis of endotoxic shock and organ failure. Molecular Medicine Today 5: 123–132.CrossRefPubMed Karima, R., S. Matsumoto, H. Higashi, and K. Matsushima. 1999. The molecular pathogenesis of endotoxic shock and organ failure. Molecular Medicine Today 5: 123–132.CrossRefPubMed
2.
Zurück zum Zitat Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. CHEST Journal 112: 235–243.CrossRef Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. CHEST Journal 112: 235–243.CrossRef
3.
Zurück zum Zitat Angus, D.C., W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303–1310.CrossRefPubMed Angus, D.C., W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303–1310.CrossRefPubMed
4.
Zurück zum Zitat Yan, Y., H. Zhou, H. Gao, L. Chen, L. Chen, L. Gao, et al. 2013. Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats. Research in Veterinary Science 94: 590–595.CrossRefPubMed Yan, Y., H. Zhou, H. Gao, L. Chen, L. Chen, L. Gao, et al. 2013. Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats. Research in Veterinary Science 94: 590–595.CrossRefPubMed
5.
Zurück zum Zitat Moss, M. 2005. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clinical Infectious Diseases 41: S490–S497.CrossRefPubMed Moss, M. 2005. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clinical Infectious Diseases 41: S490–S497.CrossRefPubMed
6.
Zurück zum Zitat Marshall, J.C. 2003. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nature Reviews Drug Discovery 2: 391–405.CrossRefPubMed Marshall, J.C. 2003. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nature Reviews Drug Discovery 2: 391–405.CrossRefPubMed
7.
Zurück zum Zitat Paterson, R., and N. Webster. 2000. Sepsis and the systemic inflammatory response syndrome. Journal of the Royal College of Surgeons of Edinburgh 45: 178–182.PubMed Paterson, R., and N. Webster. 2000. Sepsis and the systemic inflammatory response syndrome. Journal of the Royal College of Surgeons of Edinburgh 45: 178–182.PubMed
8.
Zurück zum Zitat Lappin, E., and A.J. Ferguson. 2009. Gram-positive toxic shock syndromes. The Lancet infectious diseases 9: 281–290.CrossRefPubMed Lappin, E., and A.J. Ferguson. 2009. Gram-positive toxic shock syndromes. The Lancet infectious diseases 9: 281–290.CrossRefPubMed
9.
Zurück zum Zitat Lin, Q., L. Jin, Z. Cao, H. Li, and Y. Xu. 2008. Protective effect of Acanthopanax senticosus extract against endotoxic shock in mice. Journal of Ethnopharmacology 118: 495–502.CrossRefPubMed Lin, Q., L. Jin, Z. Cao, H. Li, and Y. Xu. 2008. Protective effect of Acanthopanax senticosus extract against endotoxic shock in mice. Journal of Ethnopharmacology 118: 495–502.CrossRefPubMed
11.
Zurück zum Zitat Liu, L., Q. Mu, W. Li, W. Xing, H. Zhang, T. Fan, et al. 2015. Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes. Immunobiology 220: 406–413.CrossRefPubMed Liu, L., Q. Mu, W. Li, W. Xing, H. Zhang, T. Fan, et al. 2015. Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes. Immunobiology 220: 406–413.CrossRefPubMed
12.
Zurück zum Zitat Mei, X., D. Xu, S. Xu, Y. Zheng, and S. Xu. 2012. Novel role of Zn (II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chemico-Biological Interactions 197: 31–39.CrossRefPubMed Mei, X., D. Xu, S. Xu, Y. Zheng, and S. Xu. 2012. Novel role of Zn (II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chemico-Biological Interactions 197: 31–39.CrossRefPubMed
13.
Zurück zum Zitat Kishimote, T., S. Akira, and T. Taga. 1992. Interleukln-6 and Its Receptor: a paradigm for cytoklnes. Science 258: 593–597.CrossRef Kishimote, T., S. Akira, and T. Taga. 1992. Interleukln-6 and Its Receptor: a paradigm for cytoklnes. Science 258: 593–597.CrossRef
14.
Zurück zum Zitat Li, S., H. Bao, L. Han, and L. Liu. 2010. Effects of propofol on early and late cytokines in lipopolysaccharide-induced septic shock in rats. Journal of biomedical research 24: 389–394.CrossRefPubMedPubMedCentral Li, S., H. Bao, L. Han, and L. Liu. 2010. Effects of propofol on early and late cytokines in lipopolysaccharide-induced septic shock in rats. Journal of biomedical research 24: 389–394.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sun, N., and C. Chao. 2005. The cytokine activity of HMGB1-extracellular escape of the nuclear protein. Chang Gung Medical Journal 28: 673.PubMed Sun, N., and C. Chao. 2005. The cytokine activity of HMGB1-extracellular escape of the nuclear protein. Chang Gung Medical Journal 28: 673.PubMed
16.
Zurück zum Zitat Alves, J.N., K.M.P. Pires, M. Lanzetti, M.V. Barroso, C.F. Benjamim, C.A. Costa, et al. 2013. Critical role for CCR2 and HMGB1 in induction of experimental endotoxic shock. Archives of Biochemistry and Biophysics 537: 72–81.CrossRefPubMed Alves, J.N., K.M.P. Pires, M. Lanzetti, M.V. Barroso, C.F. Benjamim, C.A. Costa, et al. 2013. Critical role for CCR2 and HMGB1 in induction of experimental endotoxic shock. Archives of Biochemistry and Biophysics 537: 72–81.CrossRefPubMed
17.
Zurück zum Zitat Asavarut, P., H. Zhao, J. Gu, and D. Ma. 2013. The role of HMGB1 in inflammation-mediated organ injury. Acta Anaesthesiologica Taiwanica 51: 28–33.CrossRefPubMed Asavarut, P., H. Zhao, J. Gu, and D. Ma. 2013. The role of HMGB1 in inflammation-mediated organ injury. Acta Anaesthesiologica Taiwanica 51: 28–33.CrossRefPubMed
18.
Zurück zum Zitat Feng, Y., Q. Yang, J. Xu, G. Qian, and Y. Liu. 2008. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Experimental and Molecular Pathology 85: 214–222.CrossRefPubMed Feng, Y., Q. Yang, J. Xu, G. Qian, and Y. Liu. 2008. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Experimental and Molecular Pathology 85: 214–222.CrossRefPubMed
19.
Zurück zum Zitat Lappas, M., M. Permezel, H.M. Georgiou, and G.E. Rice. 2002. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biology of Reproduction 67: 668–673.CrossRefPubMed Lappas, M., M. Permezel, H.M. Georgiou, and G.E. Rice. 2002. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biology of Reproduction 67: 668–673.CrossRefPubMed
20.
Zurück zum Zitat O’Sullivan, A.W., J.H. Wang, and H.P. Redmond. 2009. NF-κB and P38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. Journal of Surgical Research 152: 46–53.CrossRefPubMed O’Sullivan, A.W., J.H. Wang, and H.P. Redmond. 2009. NF-κB and P38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. Journal of Surgical Research 152: 46–53.CrossRefPubMed
21.
Zurück zum Zitat Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344–362.CrossRefPubMed Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344–362.CrossRefPubMed
22.
Zurück zum Zitat De Stefano, D., M.C. Maiuri, B. Iovine, A. Ialenti, M.A. Bevilacqua, and R. Carnuccio. 2006. The role of NF-κB, IRF-1, and STAT-1α transcription factors in the iNOS gene induction by gliadin and IFN-γ in RAW 264.7 macrophages. Journal of Molecular Medicine 84: 65–74.CrossRefPubMed De Stefano, D., M.C. Maiuri, B. Iovine, A. Ialenti, M.A. Bevilacqua, and R. Carnuccio. 2006. The role of NF-κB, IRF-1, and STAT-1α transcription factors in the iNOS gene induction by gliadin and IFN-γ in RAW 264.7 macrophages. Journal of Molecular Medicine 84: 65–74.CrossRefPubMed
23.
Zurück zum Zitat Rim, H.K., C.H. Yun, J.S. Shin, Y.W. Cho, D.S. Jang, J.H. Ryu, et al. 2013. 5, 6, 7-Trimethoxyflavone suppresses pro-inflammatory mediators in lipopolysaccharide-induced RAW 264.7 macrophages and protects mice from lethal endotoxin shock. Food and Chemical Toxicology 62: 847–855.CrossRefPubMed Rim, H.K., C.H. Yun, J.S. Shin, Y.W. Cho, D.S. Jang, J.H. Ryu, et al. 2013. 5, 6, 7-Trimethoxyflavone suppresses pro-inflammatory mediators in lipopolysaccharide-induced RAW 264.7 macrophages and protects mice from lethal endotoxin shock. Food and Chemical Toxicology 62: 847–855.CrossRefPubMed
24.
Zurück zum Zitat Ghosh, S., and M.S. Hayden. 2008. New regulators of NF-κB in inflammation. Nature Reviews Immunology 8: 837–848.CrossRefPubMed Ghosh, S., and M.S. Hayden. 2008. New regulators of NF-κB in inflammation. Nature Reviews Immunology 8: 837–848.CrossRefPubMed
25.
Zurück zum Zitat Liu, S.F., and A.B. Malik. 2006. NF-κB activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed Liu, S.F., and A.B. Malik. 2006. NF-κB activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed
26.
Zurück zum Zitat Pande, V., and M. Ramos. 2005. NF-κB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Current Medicinal Chemistry 12: 357–374.CrossRefPubMed Pande, V., and M. Ramos. 2005. NF-κB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Current Medicinal Chemistry 12: 357–374.CrossRefPubMed
27.
Zurück zum Zitat Nogata, Y., K. Sakamoto, H. Shiratsuchi, T. Ishii, M. Yano, and H. Ohta. 2006. Flavonoid composition of fruit tissues of citrus species. Bioscience, Biotechnology, and Biochemistry 70: 178–192.CrossRefPubMed Nogata, Y., K. Sakamoto, H. Shiratsuchi, T. Ishii, M. Yano, and H. Ohta. 2006. Flavonoid composition of fruit tissues of citrus species. Bioscience, Biotechnology, and Biochemistry 70: 178–192.CrossRefPubMed
28.
Zurück zum Zitat Choi, S., H. Ko, S. Ko, J. Hwang, J. Park, S. Kang, et al. 2007. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biological and Pharmaceutical Bulletin 30: 772–778.CrossRefPubMed Choi, S., H. Ko, S. Ko, J. Hwang, J. Park, S. Kang, et al. 2007. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biological and Pharmaceutical Bulletin 30: 772–778.CrossRefPubMed
29.
Zurück zum Zitat Murakami, A., T. Shigemori, and H. Ohigashi. 2005. Zingiberaceous and citrus constituents, 1’-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 murine macrophages through different modes of action. The Journal of nutrition 135: 2987S–2992S.PubMed Murakami, A., T. Shigemori, and H. Ohigashi. 2005. Zingiberaceous and citrus constituents, 1’-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 murine macrophages through different modes of action. The Journal of nutrition 135: 2987S–2992S.PubMed
30.
Zurück zum Zitat Wu, Y., C. Zhou, J. Tao, and S. Li. 2006. Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sciences 78: 2689–2696.CrossRefPubMed Wu, Y., C. Zhou, J. Tao, and S. Li. 2006. Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sciences 78: 2689–2696.CrossRefPubMed
31.
Zurück zum Zitat Li, Y., L. Gan, G.Q. Li, L. Deng, X. Zhang, and Y. Deng. 2014. Pharmacokinetics of plantamajoside and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 89: 251–256.CrossRefPubMed Li, Y., L. Gan, G.Q. Li, L. Deng, X. Zhang, and Y. Deng. 2014. Pharmacokinetics of plantamajoside and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 89: 251–256.CrossRefPubMed
32.
Zurück zum Zitat Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251.CrossRefPubMed Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251.CrossRefPubMed
33.
Zurück zum Zitat Silva, A.T., K.F. Bayston, and J. Cohen. 1990. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor- in experimental gram-negative shock. Journal of Infectious Diseases 162: 421–427.CrossRefPubMed Silva, A.T., K.F. Bayston, and J. Cohen. 1990. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor- in experimental gram-negative shock. Journal of Infectious Diseases 162: 421–427.CrossRefPubMed
34.
Zurück zum Zitat Ohlsson, K., P. Björk, M. Bergenfeldt, R. Hageman, and R.C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550–552.CrossRefPubMed Ohlsson, K., P. Björk, M. Bergenfeldt, R. Hageman, and R.C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550–552.CrossRefPubMed
35.
Zurück zum Zitat Roth, R.I., D. Su, A.H. Child, N.R. Wainwright, and J. Levin. 1998. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia. Journal of Infectious Diseases 177: 388–394.CrossRefPubMed Roth, R.I., D. Su, A.H. Child, N.R. Wainwright, and J. Levin. 1998. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia. Journal of Infectious Diseases 177: 388–394.CrossRefPubMed
36.
Zurück zum Zitat Adib-Conquy, M., and J.M. Cavaillon. 2007. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Letters 581: 3723–3733.CrossRefPubMed Adib-Conquy, M., and J.M. Cavaillon. 2007. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Letters 581: 3723–3733.CrossRefPubMed
37.
Zurück zum Zitat Chen, F., V. Castranova, X. Shi, and L.M. Demers. 1999. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 45: 7–17.PubMed Chen, F., V. Castranova, X. Shi, and L.M. Demers. 1999. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 45: 7–17.PubMed
38.
Zurück zum Zitat Tseng, T., M. Chen, M. Tsai, Y. Hsu, C. Chen, and T.J. Lee. 2012. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents. Tseng, T., M. Chen, M. Tsai, Y. Hsu, C. Chen, and T.J. Lee. 2012. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents.
39.
Zurück zum Zitat Sun, J., G. Chi, L.W. Soromou, N. Chen, M. Guan, Q. Wu, et al. 2012. Preventive effect of imperatorin on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 14: 369–374.CrossRefPubMed Sun, J., G. Chi, L.W. Soromou, N. Chen, M. Guan, Q. Wu, et al. 2012. Preventive effect of imperatorin on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 14: 369–374.CrossRefPubMed
40.
Zurück zum Zitat Meisner, M., J. Schmidt, M. Schywalsky, and K. Tschaikowsky. 2000. Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock. International Journal of Immunopharmacology 22: 83–90.CrossRefPubMed Meisner, M., J. Schmidt, M. Schywalsky, and K. Tschaikowsky. 2000. Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock. International Journal of Immunopharmacology 22: 83–90.CrossRefPubMed
41.
Zurück zum Zitat Wang, M., T. Liu, D. Wang, Y. Zheng, X. Wang, and J. He. 2011. Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits. Journal of Translational Medicine 9: 61.CrossRefPubMedPubMedCentral Wang, M., T. Liu, D. Wang, Y. Zheng, X. Wang, and J. He. 2011. Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits. Journal of Translational Medicine 9: 61.CrossRefPubMedPubMedCentral
Metadaten
Titel
Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway
verfasst von
Weifeng Li
Xiumei Wang
Xiaofeng Niu
Hailin Zhang
Zehong He
Yu Wang
Wenbing Zhi
Fang Liu
Publikationsdatum
05.02.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0307-5

Weitere Artikel der Ausgabe 2/2016

Inflammation 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.